T1	Treatment 0 24	Doxymycine-cyanoacrylate
T2	Treatment 140 150	doxymycine
T3	Treatment 329 469	Experimental group (n = 15) received a topical application of doxymycine and controls (n = 16) received calcii gluconase in the same manner.
T4	Treatment 470 532	Medications were covered by isobutyl cyanoacrylate (Iso-Dent).
T5	Treatment 902 913	doxymycine.
T6	Treatment 986 1010	doxymycine-cyanoacrylate
T7	Treatment 1099 1109	doxymycine
